TY - JOUR
T1 - Non-invasive intracranial pressure estimation during combined exposure to CO2 and head-down tilt
AU - Kurazumi, Takuya
AU - Ogawa, Yojiro
AU - Yanagida, Ryo
AU - Morisaki, Hiroshi
AU - Iwasaki, Kenichi
N1 - Publisher Copyright:
© by the Aerospace Medical Association, Alexandria, VA.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - BACKGROUND: Exposure to carbon dioxide (CO2) and cephalad fluid shift are considered factors that affect intracranial pressure (ICP) during spaceflight. Increases in ICP were reported during cephalad fluid shift induced by head-down tilt (HDT), while little is known regarding the effect of additional CO2 during HDT on ICP. Therefore, we tested the hypothesis that this combination increases ICP more than HDT alone. METHODS: There were 15 healthy male volunteers who underwent 4 types of 10-min interventions consisting of Placebo/Supine (air and supine), CO2/Supine (3% CO2 and supine, CO2 alone), Placebo/HDT (air and 210° HDT, HDT alone), and CO2/HDT (3% CO2 and 210° HDT, combination). Using arterial blood pressure (ABP) and cerebral blood flow velocity waveforms, ICP was estimated noninvasively before and during the four interventions. Two calculation methods were employed. One is based on the signal transformation from ABP to ICP with the intracranial component as a "black box" system (nICP_BB), and the other is based on the equation ICP = ABP 2 cerebral perfusion pressure, reflecting critical closing pressure (nICP_CrCP). RESULTS: Both nICP_BB and nICP_CrCP significantly increased during Placebo/HDT and CO2/HDT, although there was no statistically significant difference between the nICP indexes of these two interventions. DISCUSSION: Increases in ICP were observed during both Placebo/HDT and CO2/HDT. Contrary to our hypothesis, the combination of 3% CO2 and 210° HDT did not increase ICP remarkably compared to 210° HDT alone. Therefore, the addition of 3% CO2 is considered to have little effect on increasing ICP during cephalad fluid shift.
AB - BACKGROUND: Exposure to carbon dioxide (CO2) and cephalad fluid shift are considered factors that affect intracranial pressure (ICP) during spaceflight. Increases in ICP were reported during cephalad fluid shift induced by head-down tilt (HDT), while little is known regarding the effect of additional CO2 during HDT on ICP. Therefore, we tested the hypothesis that this combination increases ICP more than HDT alone. METHODS: There were 15 healthy male volunteers who underwent 4 types of 10-min interventions consisting of Placebo/Supine (air and supine), CO2/Supine (3% CO2 and supine, CO2 alone), Placebo/HDT (air and 210° HDT, HDT alone), and CO2/HDT (3% CO2 and 210° HDT, combination). Using arterial blood pressure (ABP) and cerebral blood flow velocity waveforms, ICP was estimated noninvasively before and during the four interventions. Two calculation methods were employed. One is based on the signal transformation from ABP to ICP with the intracranial component as a "black box" system (nICP_BB), and the other is based on the equation ICP = ABP 2 cerebral perfusion pressure, reflecting critical closing pressure (nICP_CrCP). RESULTS: Both nICP_BB and nICP_CrCP significantly increased during Placebo/HDT and CO2/HDT, although there was no statistically significant difference between the nICP indexes of these two interventions. DISCUSSION: Increases in ICP were observed during both Placebo/HDT and CO2/HDT. Contrary to our hypothesis, the combination of 3% CO2 and 210° HDT did not increase ICP remarkably compared to 210° HDT alone. Therefore, the addition of 3% CO2 is considered to have little effect on increasing ICP during cephalad fluid shift.
KW - Cephalad fluid shift
KW - Hypercapnia
KW - Intracranial pressure
KW - Non-invasive method
KW - Transcranial Doppler ultrasonography
UR - http://www.scopus.com/inward/record.url?scp=85044871159&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044871159&partnerID=8YFLogxK
U2 - 10.3357/AMHP.5015.2018
DO - 10.3357/AMHP.5015.2018
M3 - Article
C2 - 29562966
AN - SCOPUS:85044871159
SN - 2375-6314
VL - 89
SP - 365
EP - 370
JO - Aerospace Medicine and Human Performance
JF - Aerospace Medicine and Human Performance
IS - 4
ER -